• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: clinical outcomes in lean NAFLD-the devil is in the details.

作者信息

Tan Eunice X X, Muthiah Mark Dhinesh, Ng Cheng Han, Huang Daniel Q

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

Aliment Pharmacol Ther. 2023 May;57(9):1040-1041. doi: 10.1111/apt.17449.

DOI:10.1111/apt.17449
PMID:37053487
Abstract
摘要

相似文献

1
Editorial: clinical outcomes in lean NAFLD-the devil is in the details.社论：非酒精性脂肪性肝病（NAFLD）患者的临床结局——细节决定成败。
Aliment Pharmacol Ther. 2023 May;57(9):1040-1041. doi: 10.1111/apt.17449.
2
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.社论：非酒精性脂肪性肝病（NAFLD）的临床结局——细节决定成败。作者回复。
Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.
3
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.从斯里兰卡一项为期 7 年的前瞻性社区队列研究看瘦型非酒精性脂肪性肝病（瘦型 NAFLD）的特征、代谢结局和危险因素。
Hepatol Int. 2019 May;13(3):314-322. doi: 10.1007/s12072-018-9916-4. Epub 2018 Dec 11.
4
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.非酒精性脂肪性肝病在瘦人群体中的：预后、结局和管理。
World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514.
5
Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?社论：“瘦型”非酒精性脂肪性肝病：BMI正常的代谢性肥胖……与基因有关吗？
Am J Gastroenterol. 2017 Jan;112(1):111-113. doi: 10.1038/ajg.2016.527.
6
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
7
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.瘦非酒精性脂肪性肝病患者的总热量、碳水化合物、蛋白质、脂肪、铁、睡眠时间和加班时间与肥胖非酒精性脂肪性肝病患者相当。
J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16.
8
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
9
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型中国成年人的患病率、临床特征、危险因素和指标。
World J Gastroenterol. 2020 Apr 21;26(15):1792-1804. doi: 10.3748/wjg.v26.i15.1792.
10
Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.瘦型非酒精性脂肪性肝病（NAFLD）患者的临床特征和代谢特征及其与肥胖和超重 NAFLD 的比较。
J Assoc Physicians India. 2022 Apr;70(4):11-12.

引用本文的文献

1
Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.瘦人非酒精性脂肪性肝病（NAFLD）的遗传和表观遗传决定因素：一项系统综述。
Transl Gastroenterol Hepatol. 2023 Dec 6;9:11. doi: 10.21037/tgh-23-31. eCollection 2024.
2
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.社论：非酒精性脂肪性肝病（NAFLD）的临床结局——细节决定成败。作者回复。
Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.